Scott M Arnold - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Regulatory Toxicology and Pharmacology : RTP|December 28, 2014

Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibitionScott M Arnold, Alistair Morriss, Joseph Velovitch, et al.

Regulatory Toxicology and Pharmacology : RTP|August 9, 2012

Risk assessment for consumer exposure to toluene diisocyanate (TDI) derived from polyurethane flexible foamScott M Arnold, Michael A Collins, Cynthia Graham, et al.

Neurocritical Care|October 26, 2018

Early Progressive Mobilization of Patients with External Ventricular Drains: Safety and FeasibilityRebekah A Yataco, Scott M Arnold, Suzanne M Brown, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Regulatory Toxicology and Pharmacology : RTP|December 28, 2014

Derivation of human Biomonitoring Guidance Values for chlorpyrifos using a physiologically based pharmacokinetic and pharmacodynamic model of cholinesterase inhibitionScott M Arnold, Alistair Morriss, Joseph Velovitch, et al.

Regulatory Toxicology and Pharmacology : RTP|August 9, 2012

Risk assessment for consumer exposure to toluene diisocyanate (TDI) derived from polyurethane flexible foamScott M Arnold, Michael A Collins, Cynthia Graham, et al.

Neurocritical Care|October 26, 2018

Early Progressive Mobilization of Patients with External Ventricular Drains: Safety and FeasibilityRebekah A Yataco, Scott M Arnold, Suzanne M Brown, et al.

Pageof 2